Daxxify

Daxxify (daxibotulinumtoxinA) is a next-generation botulinum toxin type A that uses a proprietary peptide stabilizer instead of human albumin, delivering longer-lasting neuromuscular relaxation than any other FDA-approved neuromodulator on the market. Clinical studies show results lasting an average of 6 months in most patients — and up to 9 months in some — compared to the typical 3–4 months seen with Botox or Dysport.

Treatment takes 15–30 minutes and targets the same dynamic wrinkles as traditional neurotoxins: forehead lines, frown lines between the brows (glabella), and crow's feet. Daxxify requires approximately double the unit count of Botox for equivalent effect in the same area, but patients who prioritize fewer office visits and extended results often find the per-session cost worthwhile over the course of a year. There is no downtime, and most patients return to normal activities immediately.

Daxxify is an excellent choice for patients already familiar with neurotoxin treatments who want longer-lasting results, or those whose Botox or Dysport results wear off faster than they'd like. It is appropriate for healthy adults looking to smooth dynamic facial wrinkles without surgery who prefer the convenience of less-frequent maintenance visits.